Preparing independent, creative leaders in the pharmaceutical sciences and in the application of genetics and genomics to the development of safe, effective drugs for patients
Nation debates possibility of dramatically new directions for health care coverage, science funding, immigration, education; Revealing malaria/HIV drug interactions in children; Decreasing cancer drug toxicity while increasing dose; Engineering safer opioids; Evidence for comprehensive medication...
Authoring the lead commentary in the current special issue of Nature devoted to diversity, School faculty member Esteban Burchard, MD, MPH, asserts that the clinical and biomedical research infrastructure “needs to be retooled” to include more diverse patient populations in studies.
Desai, a bioengineer who focuses on the design, fabrication, and use of advanced micro/nano biosystems, was chosen as a 2009 Emerging Scholar in Physiology by Diverse Issues in Higher Education.